JZG-20766-29236
2 vaccinations
1 coded response
2 check-ins
0 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 730 / OK
- Registered
- 2022-11-05
- Relationship
- Child or adolescent in my care
- Guardian
- ZT7-33100-09221
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-08-27
Dose 1 — Pfizer-BioNTech
-
2022-09-17
Dose 2 — Pfizer-BioNTech
-
2022-11-05
Registered in v-safe
- 2022-12-17
-
2023-03-18
Survey response — 6 months, dose 2, under 3MedDRA: Pyrexia, Self-medication — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-03-18
Report sent to call center — 6 months, dose 2, under 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2023-03-20
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-08-27 | Pfizer-BioNTech | No |
| 2 | 2022-09-17 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2023-03-18 | Unsuccessful |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Pyrexia | · | · | ✓ |
| SD | Self-medication | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release